Theodorus Investment Funds

Merci à tous ceux qui étaient présents en personne ou en ligne et à ceux qui ont contribué aux consultations ayant mener à ce bilan constructif de la SQRI2! Un merci particulier à Olivier Belenger de Theodorus Investment Funds et Tanya Tolomeo MSc MBA de Simmunome Inc. pour votre participation à notre panel Eurêka, animé de main de maître par Benoit M Leroux 🙌💡

Quebec is making a strategic choice by focusing on collaboration and promising partnerships to secure a leading position in the international competition for #mRNA therapies and business services in this field. Promising exchanges occurred during a panel with venture capitalists (Theodorus Investment Funds, Amplitude Ventures, Theralys), pioneering academics, Moderna, and biotech companies in the scaling-up phase). This dynamic holds great potential to accelerate innovation and growth in this key sector. Congratulations, AReNA, for this great event and insightful vision!

🚀 Breaking News : Le Startupfest décolle maintenant ! 🎉 👨⚖️👨⚖️ Notre formidable jury Alexandre Boyer, CFA, Camille Crueghe, Hugo Gamache, Justin Brasier, Nadine Carney, MBA, CPA et moi-même, sont prêts à entendre vos idées ! 💰 À la clé : notre méga bourse impact du Fonds de solidarité FTQ de 25k$ ! Non dilutif !💥 🔥 Bonus : votre startup sera catapultée dans le pipeline de nos fonds partenaires : Accelia Capital, AmorChem, AQC Capital, i4 Capital et Theodorus Investment Funds ☀️🌧️ On vous attend, qu'il pleuve ou qu'il vente ! L'innovation ne craint pas la météo ! #Startupfest #StartupfestVF #QuebecTech #StartupsQuebecoise

Gogogo !! A tous les fondateurs et fondatrices de startups de notre réseau, on ne peut que vous recommander de solliciter au prix du Fonds de solidarité FTQ pour cette édition annuelle de la Startupfest !! #startupfest #venturecapital Nicolas du Parc Patricia Escoffier, PhD Théo Risopoulos

🚀🌟 Alerte Startupfest 🌟🚀 📣 Dans une semaine, le Startupfest décolle et j'ai l'immense plaisir de rejoindre le jury du Fonds de solidarité FTQ pour propulser la startup à impact la plus innovante avec notre bourse Impact de 25 000 $ ! 🚀💼 🤝 Venez pitcher votre business model les 10 et 11 juillet et connectez avec nous. Nous serons 6 juges à l'affût de votre génie entrepreneurial ! 🧠💡 🎁 Bonus spécial : Tous les participants seront directement intégrés dans le pipeline de nos fonds partenaires : Accelia Capital, AmorChem, AQC Capital, i4 Capital et Theodorus Investment Funds. Une chance unique de booster votre visibilité et de décrocher un financement stratégique ! 🌐💰 🔥 Que le meilleur gagne ! Préparez-vous à enflammer le jury avec vos idées disruptives et à repartir avec bien plus qu'une récompense. C'est le moment de briller, startups du Québec ! ✨🏆 📢 Diffusez le message à vos startups, c'est 25 000 $ de non dilutif ! Les critères d'admissibilités sont ici : https://lnkd.in/eye98qMa #Startupfest #StartupfestVF #StartupsQuebecoises

Theodorus est fier d'annoncer sa participation dans la ronde de financement d'amorçage de la société québécoise Ability Biologics qui a pour but d'appliquer l'intelligence artificielle dans le développement de nouvelles biothérapies. Cela représente notre dixième investissement au Canada avec le fonds Theodorus IV. Bravo à toute l'équipe d'Ability Giles Day Dr. Jean-Philippe Buerckert Patrick Tremblay ! Heureux de faire partie de cette aventure avec un syndicat de grande qualité: Amplitude Ventures Fonds de solidarité FTQ Investissement Québec Alexandria Ventures ------------------------------------------------------- We are proud to back Ability Biologics in their 18M$ seed round to generate novel antibodies by using generative Artificial Intelligence. Congratulation to all the team at Ability Giles Day Dr. Jean-Philippe Buerckert Patrick Tremblay We are thrilled to join the following high-quality investors in this journey : Amplitude Ventures Fonds de solidarité FTQ Investissement Québec Alexandria Ventures

We are proud to announce that CluePoints was acquired by EQT Group, a global leader in private equity. While the transaction amount remains confidential, we are pleased to share that this deal alone returned over 3x the total amount invested by our fund Theodorus III (ULB spin-off fund). This achievement makes Theodorus III (ULB spin-off fund) the best performing fund in our 20-year history (4.5x realized total MOIC). We supported François Torche, Marc Buyse (founders), Andrew Cooper, Amit Patel and the rest of the team for the past decade, starting from their very first seed round of financing. Our thesis was straightforward: Help the pharma industry leverage AI and statistical tools to achieve better outcomes from clinical trials. We would also like to extend a special thank you to the other investors who have been with us from the beginning: Wallonie Entreprendre, invest.bw, IDDI - Regulatory Statistics & Clinical Data Science Experts and Summit Partners, which did an incredible job over the past four years with the company. Lastly a big shoutout to our fund shareholders who made this investment possible: BNP Paribas SFPIM finance&invest.brussels Université libre de Bruxelles Sambrinvest and others. #M&A #PE #Belgium #VC #Pharma #Software https://lnkd.in/e4MyCSPD

We are proud to announce that CluePoints was acquired by EQT Group, a global leader in private equity. While the transaction amount remains confidential, we are pleased to share that this deal alone returned over 3x the total amount invested by our fund Theodorus III (ULB spin-off fund). This achievement makes Theodorus III (ULB spin-off fund) the best performing fund in our 20-year history (4.5x realized total MOIC). We supported François Torche, Marc Buyse (founders), Andrew Cooper, Amit Patel and the rest of the team for the past decade, starting from their very first seed round of financing. Our thesis was straightforward: Help the pharma industry leverage AI and statistical tools to achieve better outcomes from clinical trials. We would also like to extend a special thank you to the other investors who have been with us from the beginning: Wallonie Entreprendre, invest.bw, IDDI - Regulatory Statistics & Clinical Data Science Experts and Summit Partners, which did an incredible job over the past four years with the company. Lastly a big shoutout to our fund shareholders who made this investment possible: BNP Paribas SFPIM finance&invest.brussels Université libre de Bruxelles Sambrinvest and others. #M&A #PE #Belgium #VC #Pharma #Software https://lnkd.in/e4MyCSPD

We are proud to announce that CluePoints was acquired by EQT Group, a global leader in private equity. While the transaction amount remains confidential, we are pleased to share that this deal alone returned over 3x the total amount invested by our fund Theodorus III (ULB spin-off fund). This achievement makes Theodorus III (ULB spin-off fund) the best performing fund in our 20-year history (4.5x realized total MOIC). We supported François Torche, Marc Buyse (founders), Andrew Cooper, Amit Patel and the rest of the team for the past decade, starting from their very first seed round of financing. Our thesis was straightforward: Help the pharma industry leverage AI and statistical tools to achieve better outcomes from clinical trials. We would also like to extend a special thank you to the other investors who have been with us from the beginning: Wallonie Entreprendre, invest.bw, IDDI - Regulatory Statistics & Clinical Data Science Experts and Summit Partners, which did an incredible job over the past four years with the company. Lastly a big shoutout to our fund shareholders who made this investment possible: BNP Paribas SFPIM finance&invest.brussels Université libre de Bruxelles Sambrinvest and others. #M&A #PE #Belgium #VC #Pharma #Software https://lnkd.in/e4MyCSPD

We are proud to announce that CluePoints was acquired by EQT Group, a global leader in private equity. While the transaction amount remains confidential, we are pleased to share that this deal alone returned over 3x the total amount invested by our fund Theodorus III (ULB spin-off fund). This achievement makes Theodorus III (ULB spin-off fund) the best performing fund in our 20-year history (4.5x realized total MOIC). We supported François Torche, Marc Buyse (founders), Andrew Cooper, Amit Patel and the rest of the team for the past decade, starting from their very first seed round of financing. Our thesis was straightforward: Help the pharma industry leverage AI and statistical tools to achieve better outcomes from clinical trials. We would also like to extend a special thank you to the other investors who have been with us from the beginning: Wallonie Entreprendre, invest.bw, IDDI - Regulatory Statistics & Clinical Data Science Experts and Summit Partners, which did an incredible job over the past four years with the company. Lastly a big shoutout to our fund shareholders who made this investment possible: BNP Paribas SFPIM finance&invest.brussels Université libre de Bruxelles Sambrinvest and others. #M&A #PE #Belgium #VC #Pharma #Software https://lnkd.in/e4MyCSPD